- Home
- OBIO vs CARE Comparison
OBIO vs CARE Comparison
Compare OBIO & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- CARE
- Stock Information
- Founded
- OBIO 2017
- CARE 1974
- Country
- OBIO United States
- CARE United States
- Employees
- OBIO N/A
- CARE N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- CARE Major Banks
- Sector
- OBIO Health Care
- CARE Finance
- Exchange
- OBIO Nasdaq
- CARE Nasdaq
- Market Cap
- OBIO 200.5M
- CARE 395.7M
- IPO Year
- OBIO N/A
- CARE N/A
- Fundamental
- Price
- OBIO $5.42
- CARE $18.84
- Analyst Decision
- OBIO Strong Buy
- CARE Buy
- Analyst Count
- OBIO 4
- CARE 2
- Target Price
- OBIO $15.75
- CARE $21.50
- AVG Volume (30 Days)
- OBIO 53.5K
- CARE 57.1K
- Earning Date
- OBIO 11-11-2024
- CARE 10-28-2024
- Dividend Yield
- OBIO N/A
- CARE N/A
- EPS Growth
- OBIO N/A
- CARE N/A
- EPS
- OBIO N/A
- CARE 0.54
- Revenue
- OBIO $2,079,000.00
- CARE $125,733,000.00
- Revenue This Year
- OBIO $7.68
- CARE N/A
- Revenue Next Year
- OBIO $110.40
- CARE $10.36
- P/E Ratio
- OBIO N/A
- CARE $35.03
- Revenue Growth
- OBIO N/A
- CARE N/A
- 52 Week Low
- OBIO $4.22
- CARE $10.43
- 52 Week High
- OBIO $11.69
- CARE $18.84
- Technical
- Relative Strength Index (RSI)
- OBIO 53.12
- CARE 75.68
- Support Level
- OBIO $4.96
- CARE $16.97
- Resistance Level
- OBIO $5.99
- CARE $17.44
- Average True Range (ATR)
- OBIO 0.36
- CARE 0.34
- MACD
- OBIO 0.12
- CARE 0.13
- Stochastic Oscillator
- OBIO 57.14
- CARE 100.00
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. The Bank offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.